Current Edition

Eylea

Kodiak crashes on negative trial results for would-be Eylea competitor

Dive Brief: Shares in Kodiak Sciences plummeted by 80% in Wednesday morning trading, erasing about $2 billion in market value, after the biotech company’s experimental …

Continue Reading →